Literature DB >> 6319288

Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B.

C C Tsai, B J Shenker, J M DiRienzo, D Malamud, N S Taichman.   

Abstract

A leukotoxin from Actinobacillus actinomycetemcomitans was isolated by a procedure that includes polymyxin B extraction, ion-exchange chromatography, and gel filtration chromatography. The procedure resulted in the recovery of 48% of the toxin with a 99-fold increase in specific activity. The isolated toxin has a molecular mass of 180,000 daltons by gel filtration and 115,000 daltons by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. It retains all the major biological characteristics previously documented for crude leukotoxin preparations, including susceptibility to heat and proteolytic enzymes and neutralization by sera from patients with juvenile periodontitis. The isolated leukotoxin destroys human but not rat or guinea pig polymorphonuclear leukocytes and has no apparent effect on human erythrocytes. The availability of the A. actinomycetemcomitans leukotoxin should facilitate studies on its chemistry and mode of action as well as its role in the pathogenesis of human periodontal disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319288      PMCID: PMC264356          DOI: 10.1128/iai.43.2.700-705.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Extraction and partial characterization of a leukotoxin from a plaque-derived Gram-negative microorganism.

Authors:  C C Tsai; W P McArthur; P C Baehni; B F Hammond; N S Taichman
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

2.  Collagenolytic activity associated with Bacteroides species and Actinobacillus actinomycetemcomitans.

Authors:  P B Robertson; M Lantz; P T Marucha; K S Kornman; C L Trummel; S C Holt
Journal:  J Periodontal Res       Date:  1982-05       Impact factor: 4.419

3.  Actinobacillus actinomycetemcomitans in human periodontal disease. Association, serology, leukotoxicity, and treatment.

Authors:  J Slots; J J Zambon; B G Rosling; H S Reynolds; L A Christersson; R J Genco
Journal:  J Periodontal Res       Date:  1982-09       Impact factor: 4.419

4.  Identification and characterization of the major cell envelope proteins of oral strains of Actinobacillus actinomycetemcomitans.

Authors:  J M Di Rienzo; E L Spieler
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

5.  Shigella dysenteriae 1 cytotoxin: periplasmic protein releasable by polymyxin B and osmotic shock.

Authors:  A Donohue-Rolfe; G T Keusch
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

6.  Release of Shiga toxin from Shigella dysenteriae 1 by polymyxin B.

Authors:  D E Griffin; P Gemski
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

7.  Inhibition of fibroblast proliferation by Actinobacillus actinomycetemcomitans.

Authors:  B J Shenker; M E Kushner; C C Tsai
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

8.  Bacteriology of severe periodontitis in young adult humans.

Authors:  W E Moore; L V Holdeman; R M Smibert; D E Hash; J A Burmeister; R R Ranney
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

9.  Polymyxin B-Induced Release of Low-Molecular-Weight, Heat-Labile Enterotoxin from Escherichia coli.

Authors:  D J Evans; D G Evans; S L Gorbach
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

10.  Leukotoxicity of an extract from Actinobacillus actinomycetemcomitans for human gingival polymorphonuclear leukocytes.

Authors:  N S Taichman; J M Wilton
Journal:  Inflammation       Date:  1981-03       Impact factor: 4.092

View more
  63 in total

1.  Identification of Actinobacillus actinomycetemcomitans serotypes by multiplex PCR.

Authors:  N Suzuki; Y Nakano; Y Yoshida; D Ikeda; T Koga
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Legionella pneumophila entry gene rtxA is involved in virulence.

Authors:  S L Cirillo; L E Bermudez; S H El-Etr; G E Duhamel; J D Cirillo
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Secretion of RTX leukotoxin by Actinobacillus actinomycetemcomitans.

Authors:  S C Kachlany; D H Fine; D H Figurski
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

4.  Regulation of leukotoxin in leukotoxic and nonleukotoxic strains of Actinobacillus actinomycetemcomitans.

Authors:  J Spitznagel; E Kraig; D Kolodrubetz
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

5.  Intra-oral colonization of macaque monkeys by Actinobacillus actinomycetemcomitans.

Authors:  D Beighton; N S Taichman; D L Simpson; J M Dirienzo; N W Johnson
Journal:  Oral Microbiol Immunol       Date:  1989-03

6.  TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.

Authors:  Juan A Crosby; Scott C Kachlany
Journal:  Gene       Date:  2006-10-17       Impact factor: 3.688

7.  Tumor necrosis factor alpha enhances Actinobacillus actinomycetemcomitans leukotoxin-induced HL-60 cell apoptosis by stimulating lymphocyte function-associated antigen 1 expression.

Authors:  Noboru Yamaguchi; Chie Kubo; Yoshikazu Masuhiro; Edward T Lally; Toshihiko Koga; Shigemasa Hanazawa
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Cloning and expression of the leukotoxin gene from Actinobacillus actinomycetemcomitans.

Authors:  D Kolodrubetz; T Dailey; J Ebersole; E Kraig
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

Review 9.  Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.

Authors:  Eric Krueger; Angela C Brown
Journal:  Mol Oral Microbiol       Date:  2020-03-10       Impact factor: 3.563

10.  Avidity of antibody responses to Actinobacillus actinomycetemcomitans in periodontitis.

Authors:  D S O'Dell; J L Ebersole
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.